Table 2.
Material | Virus/Disease | Recognition Element |
Dynamic Range | LOD | Real Sample | Reference |
---|---|---|---|---|---|---|
AuNRs | HBV | ssDNA | 0.045 to 6.0 nM | 15 pM | Human blood | [68] |
Ag@SiO2 nanoparticles | H5N1 influenza virus | aptamer | 2 to 200 ng/mL (in buffer) 3.5 to 100 ng/mL (in serum) |
2 ng/mL (in buffer) 3.5 ng/mL (in serum) |
Human serum | [83] |
GO | Ebola virus gene influenza |
dsDNA | 30 fM–3 nM | 1.4 pM | Human serum | [90] |
AuNPs-GO | HIV-1 gene | dsDNA | 50 fM–1 nM | 15 fM | Human serum | [91] |
AgNCs/GO | HIV | dsDNA | 10–200 nM | 1.18 nM | Human serum | [92] |
g-C3N4 Graphitic carbon nitride (gC3N4) nanosheets | HBV gene | DNA | 2–100 nM | 1 nM | Human serum | [93] |
rGONs | HCV | dsDNA | - | 10 fM | Human serum | [94] |
GO | Influenza virus H3N2 Henagglutinin gene | RNA | 37–9400 pg | 3.8 pg | - | [95] |
QDs | HIV, HBV | DNA | 103 to 109 copies/mL | 1 × 103 copies/mL | Human serum | [96] |
QDs | Influenza (H1N1) | aptamer | 10 nM–100 nM | 3.45 nM | - | [97] |
AuNPs | SARS-CoV-2 | DNA | 0.01–1 pM | 160 fM | - | [98] |